title: Sweet's syndrome induced by oral contraceptive.
authors.forename: M
authors.initials: M
authors.lastname: Sáez
authors.forename: M
authors.initials: M
authors.lastname: García-Bustínduy
authors.forename: A
authors.initials: A
authors.lastname: Noda
authors.forename: F
authors.initials: F
authors.lastname: Guimerá
authors.forename: S
authors.initials: S
authors.lastname: Dorta
authors.forename: M
authors.initials: M
authors.lastname: Escoda
authors.forename: E
authors.initials: E
authors.lastname: Fagundo
authors.forename: R
authors.initials: R
authors.lastname: Sánchez
authors.forename: A
authors.initials: A
authors.lastname: Martín-Herrera
authors.forename: R
authors.initials: R
authors.lastname: García Montelongo
mesh_terms: D000328:Adult; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008599:Menstruation Disturbances / Q000188:drug therapy; D000068656:Mometasone Furoate; D011241:Prednisone / Q000008:administration & dosage; D011244:Pregnadienediols / Q000008:administration & dosage; D016463:Sweet Syndrome / Q000139:chemically induced* / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D003276:Contraceptives, Oral; D011244:Pregnadienediols; D000068656:Mometasone Furoate; D011241:Prednisone